Rohto to Initiate Japan PI of JAK Inhibitor in Ophthalmology Field Later This Month

Rohto Pharmaceutical will initiate a PI clinical trial of the JAK inhibitor ROH-201 (delgocitinib) in Japan this month. The company will develop it as treatment in the field of ophthalmology but has not announced its expected indication. ROH-201 was discovered...read more